Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 16/20 | 0.44 |
| ▸ | JAK1 | P23458 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25288885 | 0.85 | POLB (0.48) | TYK2JAK1POLBGAAEGFR | |
| SCHEMBL25242554 | 0.84 | POLB (0.47) | TYK2JAK1POLBGAAEGFR | |
| SCHEMBL25288507 | 0.83 | POLB (0.46) | TYK2JAK1POLBGAAEGFR | |
| SCHEMBL25244650 | 0.83 | TYK2 (0.59) | TYK2JAK1POLBGAA | |
| SCHEMBL25288626 | 0.80 | TYK2 (0.45) | TYK2JAK1POLBGAAEGFR | |
| SCHEMBL25283977 | 0.78 | TYK2 (0.50) | TYK2JAK1POLBGAA | |
| SCHEMBL25242097 | 0.78 | TYK2 (0.52) | TYK2JAK1POLBGAA | |
| SCHEMBL25293421 | 0.78 | GAA (0.53) | TYK2JAK1POLBGAAEGFR | |
| SCHEMBL25239536 | 0.77 | TYK2 (0.47) | TYK2JAK1POLBGAA | |
| SCHEMBL25286198 | 0.76 | TYK2 (0.45) | TYK2JAK1POLBGAAEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4206196-A1 | PYRIMIDINE SUBSTITUTED DERIVATIVES AS TYK2 INHIBITORS | Almirall S.A. (ES) | 2023-07-05 | — | — | EP | claimed |
| EP-4206196-A1 | PYRIMIDINE SUBSTITUTED DERIVATIVES AS TYK2 INHIBITORS | Almirall S.A. (ES) | 2023-07-05 | — | — | EP | disclosed |